Hepatitis B: all 1,662 studies
Page 14 of 17. Open to participants first (192), then studies with results posted, then the rest; newest registration first within each.
- Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B PatientsCompletedNCT01356901
- Lamivudine and Adefovir Dipivoxil Fixed Dose CombinationCompletedNCT01353742Phase 1
- Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV InfectionCompletedNCT01350648
- Immunogenicity and Safety of the Hepatitis B Vaccine Hepavax-Gene TF and a Comparator Hepatitis B Vaccine in NewbornsCompletedNCT01349283Phase 3
- A Study Evaluating the Efficacy of Glucocorticoids in Patients With Pre-ACLF-HBVStatus unknownNCT01344174Not applicable
- Efficacy of Medical Ozone Therapy in Patients With Chronic Hepatitis BStatus unknownNCT01342185Phase 3
- Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC TherapyStatus unknownNCT01341743Phase 4
- Adolescents' Response to Hepatitis B Vaccine Booster DoseStatus unknownNCT01341275Phase 4
- Induction of Fibrosis Regression on Patients With Chronic Hepatitis B InfectionTerminatedNCT01341106Phase 4
- Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase LevelsCompletedNCT01337791Phase 4
- A Phase IIIb: Long-Term Outcomes for Hepatitis B (HepB) Patients in Some Previous Entecavir (ETV) TrialsCompletedNCT01337479
- Rollover Protocol Continued Access to Tenofovir Disoproxil Fumarate (TDF) for Subjects in TaiwanCompletedNCT01334567Phase 2
- Entecavir for Chronic Hepatitis BCompletedNCT01323452
- Behavioral Science Aspects of Rapid Test AcceptanceCompletedNCT01317784Not applicable
- The Antiviral Therapy in Pregnant Women to Reduce Mother-to-infant Transmission of Hepatitis B Virus-drug TestStatus unknownNCT01312012Phase 4
- Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis BCompletedNCT01311947
- Factors Influencing Hepatitis B Virus Reactivation in Lymphoma Patients Treated With RituximabCompletedNCT01311232
- The Development of Diagnostic Biomarker Panels for Hepatitis and Liver CancerStatus unknownNCT01310062
- HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis BActive, not recruitingNCT01298037
- Edible Hepatitis B Vaccine Therapy in Healthy Participants Who Have Undergone Previous VaccinationWithdrawnNCT01292421Not applicable
- Modified Dose and Schedule of Recombinant Hepatitis B Vaccination in HIV-infected Adult SubjectsStatus unknownNCT01289106Phase 3
- An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HbeAg-negative Chronic Hepatitis B (Perseas)CompletedNCT01283074
- Long-Term Study on Safety and Immunogenicity of HEPLISAV™ and Engerix-B® in Adults With Chronic Kidney DiseaseCompletedNCT01282762
- Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infectionStatus unknownNCT01273142
- Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation TherapyStatus unknownNCT01270178
- Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis BStatus unknownNCT01270165Phase 3
- Long-term Study on Anti-HBV Effect of Tenofovir and Resistance Surveillance in Asian-American Adult PatientsCompletedNCT01267162
- A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV PatientsTerminatedNCT01266005Phase 4
- A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)CompletedNCT01264367Phase 4
- An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis BCompletedNCT01264354Phase 4
- A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis BTerminatedNCT01264133Phase 4
- An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related Symptom of Chronic Hepatitis B Patients Who Received ClevudineCompletedNCT01264107
- A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long PeriodTerminatedNCT01264094Phase 4
- Hepatitis B Research Network Pediatric Cohort Study (HBRN)CompletedNCT01263600
- Hepatitis B Research Network Adult Cohort StudyCompletedNCT01263587
- A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Proportion to Roadmap Concept in Patients With HBV Associated-HCCCompletedNCT01263002Phase 4
- Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B PatientsWithdrawnNCT01260610Not applicable
- Hepatitis B Vaccination Through Syringe Exchange Programs: A Randomized, Controlled Trial of Vaccination SchedulesCompletedNCT01259453Phase 4
- The Efficacy and Safety of Entecavir Treatment of Patients With Acute on Chronic Hepatitis B Liver FailureCompletedNCT01254994Phase 2
- Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis BStatus unknownNCT01243281Not applicable
- Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis BStatus unknownNCT01242787Phase 2
- Analysis of HBV-Specific Immune Response in Patients With HBeAg Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a (40KD)) - Immunology Sub-Study of ML18253CompletedNCT01237496Phase 3
- Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.Status unknownNCT01220596Phase 3
- A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B InfectionTerminatedNCT01217632Phase 2
- Follow Up of Patients Chronic Hepatitis B (CHB) Treated With Sebivo Using the 13C Methacetin Breath TestWithdrawnNCT01204827Phase 2/3
- Dose Ranging Study of Pegylated Interferon Lambda in Patients With Hepatitis B and Positive for the Hepatitis B e AntigenCompletedNCT01204762Phase 2
- Safety and Immunogenicity of HEPLISAV™ a Hepatitis B Virus Vaccine in Adults on HemodialysisCompletedNCT01195246Phase 3
- An Study of Efficacy and Safety of ClevudineCompletedNCT01192854Phase 3
- A Clinical Study on Therapeutic Double-plasmid Hepatitis B Virus (HBV) DNA Vaccine in Patients With HBeAg-positive Chronic Hepatitis BStatus unknownNCT01189656Phase 2
- The Safety and Immunogenicity of Recombinant Hepatitis B Vaccines in the Health NeonatesCompletedNCT01183611Phase 3
- Duration of Long-term Immunity After Hepatitis B Virus ImmunizationCompletedNCT01182311
- A Study of 48 Versus 96 Weeks of Peginterferon Alfa-2a [Pegasys] Treatment, With or Without Entecavir, in Patients With Chronic Hepatitis B.WithdrawnNCT01179594Phase 4
- A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis BStatus unknownNCT01172392Phase 3
- Epidemiological Study in Children and Adolescents With Chronic Hepatitis BCompletedNCT01163240
- Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB)CompletedNCT01155427
- Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B PatientsStatus unknownNCT01148576Phase 4
- Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis BCompletedNCT01143662Phase 2
- Prophylaxis of Hepatitis B Virus Recurrence After Liver TransplantationStatus unknownNCT01139203Not applicable
- Improved Prevention of Perinatal Hepatitis B TransmissionStatus unknownNCT01133184Phase 4
- Lamivudine(LAM) Good Responder StudyCompletedNCT01128686
- Combination Hepatitis A and B Vaccine to Induce Immunity in Non-respondersWithdrawnNCT01126853Phase 4
- Safety Study of a Tenofovir-containing Drug Regimen for the Prevention of Mother-to-child Transmission of HIV and HBVCompletedNCT01125696Phase 2
- Brief Intervention for Drug Misuse in the Emergency DepartmentCompletedNCT01124591Phase 2
- Observe Change of Endotoxaemia and Related Mediators in Patients With Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT01107483
- Antibody Persistence in Healthy Children After Primary and Booster DTaP-IPV-Hep B-PRP-T Vaccine or Control VaccineCompletedNCT01105559
- Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) TherapyStatus unknownNCT01102335Phase 4
- Patients With Chronic Hepatitis B and Low Viremia Not Receiving Antiviral TherapyStatus unknownNCT01090531
- Efficacy Optimizing Research of Lamivudine TherapyCompletedNCT01088009Phase 4
- A Study of Peginterferon Alfa-2a [PEGASYS] in Patients With Chronic Hepatitis B Who Are HBeAg PositiveCompletedNCT01086085Phase 4
- The Beneficial Effect of Vitamin D Supplement to Peg Interferon Alpha 2a or to Telbivudine Monotherapy in Patients With Chronic Hepatitis B Virus (HBV) InfectionStatus unknownNCT01083251Not applicable
- Randomized Controlled Trial of Tenofovir in Patients of Reactivation of Hepatitis B Presenting as Acute on Chronic Liver FailureCompletedNCT01074645Phase 4
- Health Promotion and Management for Hepatitis B CarriersStatus unknownNCT01065363Not applicable
- Notification of Donors With Positive Microbiology MarkersCompletedNCT01050881
- Prevention of Hepatitis B Virus Reinfection After Liver Transplantation With EntecavirCompletedNCT01046799Phase 3
- Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine TherapyCompletedNCT01037166Phase 2
- An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B InfectionCompletedNCT01037062Phase 2
- Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected PatientsStatus unknownNCT01027065Phase 1/2
- Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis BCompletedNCT01026610Phase 2
- A Study to Assess DV-601 in Subjects With Chronic Hepatitis BCompletedNCT01023230Phase 1
- A Phase II Dose Response Study in Japan in Chronic Hepatitis BCompletedNCT01022801Phase 2
- Raltegravir in Patients With End Stage Liver Disease and in Transplant RecipientsCompletedNCT01022476Phase 1/2
- A Study in Japan of the Safety and Antiviral Activity With Chronic Hepatitis B InfectionCompletedNCT01020565Phase 2
- Arabinoxylan Rice Bran (MGN-3/Biobran) for the Treatment of Hepatocellular Carcinoma and Hepatitis B and C InfectionCompletedNCT01018381Not applicable
- Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral LoadCompletedNCT01013272Not applicable
- Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With TelbivudineTerminatedNCT01005238Phase 4
- Simvastatin for the Treatment of Chronic Hepatitis BCompletedNCT00994773Phase 1
- Safety and Immunogenicity of a Naked DNA-based Vaccine Therapy in Patients With Chronic Hepatitis BCompletedNCT00988767Phase 1
- Entecavir Plus Adefovir in Lamivudine-Resistant PatientsWithdrawnNCT00986778Phase 4
- Continue Entecavir Rollover From ChinaCompletedNCT00975091Phase 3
- Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral LoadCompletedNCT00973219Not applicable
- Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection SubjectsTerminatedNCT00964665Phase 1/2
- A Study of Pegasys Monotherapy in Patients With Chronic Hepatitis B Who Have Participated in Previous StudiesCompletedNCT00962975Phase 1
- TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)Status unknownNCT00960518Phase 2
- Therapeutic Effects of Liver Failure Patients Caused by Chronic Hepatitis B After Autologous MSCs TransplantationCompletedNCT00956891
- Investigation of Hepatitis B and Hepatitis C in TaiwanCompletedNCT00946010
- Efficacy and Safety Study of Telbivudine to Prevent Perinatal TransmissionStatus unknownNCT00939068Phase 4
- Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable DiseaseStatus unknownNCT00932269
- Incidence of Hepatitis B Reactivation in Non-Hodgkin's Lymphoma PatientsStatus unknownNCT00931229Not applicable
- Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis BCompletedNCT00926757Phase 4
- Hepatitis B Virus (HBV) Prevention for Homeless at Risk for HBV/Hepatitis C Virus (HCV)/HIVCompletedNCT00926146Not applicable